Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00009243 · ClinicalTrials.gov registry record

Natural History of Stroke: Cause and Development

A clinical trial of Vascular Diseases and Cerebrovascular Accident, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Recruiting
Registry status
4,000
Enrollment target
3
Study locations

NCT00009243: Recruiting study of Vascular Diseases and Cerebrovascular Accident, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00009243 is a study of Vascular Diseases and Cerebrovascular Accident that is actively recruiting participants, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 4,000 participants, above the 461-participant average among 40 other Vascular Diseases trials with a reported enrollment target (768% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00009243, a study of Vascular Diseases and Cerebrovascular Accident, is actively recruiting participants, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

RECRUITING
Registry status
4,000 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to learn more about stroke and obtain information that may serve as the basis for future investigations. It will 1) establish a registry of patients with cerebrovascular disease (stroke); 2) characterize the natural history of acute stroke and transient ischemic attacks (TIA)-an interruption of blood flow to the brain that causes stroke symptoms for a short period of time); and 3) evaluate the data to generate ideas for future studies. Patients 18 years of age or older with suspected acute stroke or TIA may be eligible for this study. Subjects will be recruited from patients who present with stroke at the emergency department of Suburban Hospital in Bethesda, Maryland. The study will gather data collected from diagnostic and laboratory tests the patient undergoes as part of standard medical care, including findings of medical and neurological examinations and other tests. In addition, studies will be done for research purposes only to gather data about stroke and TIA. These may include the following: * Blood and urine tests not more than 2 tablespoons of blood will be drawn for various tests. * Electrocardiogram (EKG) (heart tracing)-electrodes placed on the chest wall detect the heartbeat and heart rhythm. * Computed tomography (CT) scan of the head-specialized X-rays are used to obtain images of the brain. * Magnetic resonance imaging (MRI) of the brain-a strong magnetic field and radio waves are used to produce images that provide information about the brain tissue and blood vessels. * Transcranial Doppler (TCD)-sound waves are used to image the arteries of the brain and neck. * Echocardiogram-sound waves are used to image the heart and evaluate heart function. Patients may be asked to return to Suburban Hospital for follow-up testing in 1, 3, and/or 12 months, when some of these tests may be repeated to assess changes over time

Primary Outcome

Neuroimaging abnormalities, such as:-Imaging positive for acute ischemic cerebral vascular syndrome ( AICS positive )-Presence of a lesion on diffusion, perfusion, and mismatch between the two-Evidence of a vascular occlusion on MR angiography-Evidence of a thrombus or hemorrhage on T2\* GRE imaging-Blood-brain barrier disruption as evidence by "HARM"-The evolution of these markers with time and treatment

Study Locations (3)

Maryland

  • Suburban Hospital - Johns Hopkins Medicine - Bethesda
  • National Institutes of Health Clinical Center - Bethesda

District of Columbia

  • Medstar Washington Hospital Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2001-01-26

What NCT00009243 shows while recruiting

NCT00009243 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 461-participant average among 40 other Vascular Diseases trials with a reported enrollment target (768% higher).

The record links to 5 conditions, with Vascular Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT00009243 reports a single indexed study location in Maryland, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00009243 about?

NCT00009243 is a clinical study titled "Natural History of Stroke: Cause and Development". The purpose of this study is to learn more about stroke and obtain information that may serve as the basis for future investigations. It will 1) establish a registry of patients with cerebrovascular disease (stroke); 2) characterize the natural history of acute stroke and transient ischemic attacks ...

What is the current status of trial NCT00009243?

This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2001-01-26.

What conditions does trial NCT00009243 study?

This clinical trial studies the following conditions: Vascular Diseases, Cerebrovascular Accident, Brain Disease, Cerebrovascular Disorder, Ischemic Attack, Transient.

Who is sponsoring clinical trial NCT00009243?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00009243 being conducted?

This trial has 3 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00009243's enrollment target sits among peer trials

4,000 2nd of 40 the highest of 40 other Vascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Vascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00227253 · 4,000 participants

    Chromosome 18 Clinical Research Center

  • NCT00811148 · 4,000 participants

    Florida Center for Brain Tumor Research

  • NCT00897117 · 4,000 participants

    Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

  • NCT00899301 · 4,000 participants

    Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00009243, the US trial registry maintained by the National Library of Medicine. NCT00009243 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.